The role of preoperative testing on outcomes after sling surgery for stress urinary incontinence.

PubWeight™: 0.93‹?›

🔗 View Article (PMID 17706717)

Published in J Urol on August 16, 2007

Authors

Jennifer T Anger1, Larissa V Rodríguez, Qin Wang, Chris L Pashos, Mark S Litwin

Author Affiliations

1: Department of Urology, David Geffen School of Medicine and School of Public Health, University of California, Los Angeles, CA 90404, USA. janger@mednet.ucla.edu

Articles by these authors

Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med (2008) 18.60

Fever with thrombocytopenia associated with a novel bunyavirus in China. N Engl J Med (2011) 13.18

Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet (2013) 8.24

The health economics of bladder cancer: a comprehensive review of the published literature. Pharmacoeconomics (2003) 4.99

The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CapSURE), a national disease registry. J Urol (2004) 4.66

The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy. J Urol (2005) 4.40

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet (2013) 4.35

Utilization and outcomes of minimally invasive radical prostatectomy. J Clin Oncol (2008) 4.23

Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer. J Clin Oncol (2002) 4.13

Role of surgeon volume in radical prostatectomy outcomes. J Clin Oncol (2003) 4.11

Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer. Cancer (2007) 3.92

Prediction of erectile function following treatment for prostate cancer. JAMA (2011) 3.92

Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet (2013) 3.81

Effect of age, tumor risk, and comorbidity on competing risks for survival in a U.S. population-based cohort of men with prostate cancer. Ann Intern Med (2013) 3.74

Donepezil in patients with subcortical vascular cognitive impairment: a randomised double-blind trial in CADASIL. Lancet Neurol (2008) 3.41

Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nat Genet (2012) 3.20

Nonsynaptic GABA signaling in postnatal subventricular zone controls proliferation of GFAP-expressing progenitors. Nat Neurosci (2005) 3.17

Demographic and clinical characteristics of men with chronic prostatitis: the national institutes of health chronic prostatitis cohort study. J Urol (2002) 3.14

Gonadotropin-releasing hormone agonists and fracture risk: a claims-based cohort study of men with nonmetastatic prostate cancer. J Clin Oncol (2005) 2.87

Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial. Ann Intern Med (2004) 2.82

The economic impact of chronic prostatitis. Arch Intern Med (2004) 2.74

Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data. Clin Ther (2006) 2.73

Economic costs of overactive bladder in the United States. Urology (2009) 2.68

Alfuzosin and symptoms of chronic prostatitis-chronic pelvic pain syndrome. N Engl J Med (2008) 2.66

Spirituality influences health related quality of life in men with prostate cancer. Psychooncology (2006) 2.65

Overtreatment of men with low-risk prostate cancer and significant comorbidity. Cancer (2010) 2.61

Quality-of-care indicators for early-stage prostate cancer. J Clin Oncol (2003) 2.44

Geographic and socioeconomic variation in the treatment of prostate cancer. J Clin Oncol (2005) 2.41

Diffusion of surgical innovation among patients with kidney cancer. Cancer (2008) 2.38

Prostate cancer severity among low income, uninsured men. J Urol (2008) 2.38

Survivorship beyond convalescence: 48-month quality-of-life outcomes after treatment for localized prostate cancer. J Natl Cancer Inst (2009) 2.28

Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers. Am J Hum Genet (2013) 2.24

Marine cloud brightening. Philos Trans A Math Phys Eng Sci (2012) 2.23

Effectiveness and tolerability of high-dose (23 mg/d) versus standard-dose (10 mg/d) donepezil in moderate to severe Alzheimer's disease: A 24-week, randomized, double-blind study. Clin Ther (2010) 2.19

Early diagnosis of novel SFTS bunyavirus infection by quantitative real-time RT-PCR assay. J Clin Virol (2011) 2.19

Use of radical cystectomy for patients with invasive bladder cancer. J Natl Cancer Inst (2010) 2.17

Comorbidity and competing risks for mortality in men with prostate cancer. Cancer (2011) 2.17

Validation of a modified National Institutes of Health chronic prostatitis symptom index to assess genitourinary pain in both men and women. Urology (2009) 2.16

Hypothesis testing and power calculations for taxonomic-based human microbiome data. PLoS One (2012) 2.15

Comparative effectiveness of aggressive versus nonaggressive treatment among men with early-stage prostate cancer and differing comorbid disease burdens at diagnosis. Cancer (2014) 2.07

Quality of diagnostic staging in patients with bladder cancer: a process-outcomes link. Cancer (2014) 2.06

Reversible methylation of promoter-bound STAT3 by histone-modifying enzymes. Proc Natl Acad Sci U S A (2010) 2.06

Investigation of resistive switching in Cu-doped HfO2 thin film for multilevel non-volatile memory applications. Nanotechnology (2009) 2.06

The prevalence of urinary incontinence among community dwelling adult women: results from the National Health and Nutrition Examination Survey. J Urol (2006) 2.02

Mortality increases when radical cystectomy is delayed more than 12 weeks: results from a Surveillance, Epidemiology, and End Results-Medicare analysis. Cancer (2009) 1.95

Membrane trafficking of G protein-coupled receptors. Annu Rev Pharmacol Toxicol (2004) 1.94

Renal and cardiovascular morbidity after partial or radical nephrectomy. Cancer (2008) 1.89

Outcomes of vaginal prolapse surgery among female Medicare beneficiaries: the role of apical support. Obstet Gynecol (2013) 1.88

Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk. PLoS Genet (2013) 1.88

Recurrence of high-risk bladder cancer: a population-based analysis. Cancer (2013) 1.87

Correlates of bother following treatment for clinically localized prostate cancer. J Urol (2010) 1.82

19p13.1 is a triple-negative-specific breast cancer susceptibility locus. Cancer Res (2012) 1.81

CCG-1423: a small-molecule inhibitor of RhoA transcriptional signaling. Mol Cancer Ther (2007) 1.80

Variation in continence and potency by definition. J Urol (2003) 1.75

Structural basis of the recognition of a methylated histone tail by JMJD2A. Proc Natl Acad Sci U S A (2007) 1.74

Quality of care in patients with bladder cancer: a case report? Cancer (2011) 1.73

Differing perceptions of quality of life in patients with prostate cancer and their doctors. J Urol (2009) 1.72

Ten-year experience with transvaginal vesicovaginal fistula repair using tissue interposition. J Urol (2003) 1.72

Pathogenesis of emerging severe fever with thrombocytopenia syndrome virus in C57/BL6 mouse model. Proc Natl Acad Sci U S A (2012) 1.71

Variations in reconstruction after radical cystectomy. Cancer (2006) 1.69

Comorbidities, treatment and ensuing survival in men with prostate cancer. J Gen Intern Med (2011) 1.69

Natural history of bone complications in men with prostate carcinoma initiating androgen deprivation therapy. Cancer (2004) 1.64

Urinary diversion and morbidity after radical cystectomy for bladder cancer. Cancer (2010) 1.63

Host cytokine storm is associated with disease severity of severe fever with thrombocytopenia syndrome. J Infect Dis (2012) 1.62

The demographic burden of urologic diseases in America. Urol Clin North Am (2009) 1.61

Improved prediction of long-term, other cause mortality in men with prostate cancer. J Urol (2011) 1.59

Severity of comorbidity and non-prostate cancer mortality in men with early-stage prostate cancer. Arch Intern Med (2010) 1.59

Medicago truncatula mutants demonstrate the role of plant calcium oxalate crystals as an effective defense against chewing insects. Plant Physiol (2006) 1.57

Prediction of first events of coronary heart disease and stroke with consideration of adiposity. Circulation (2008) 1.56

Prognostic significance of HER2 expression based on trastuzumab for gastric cancer (ToGA) criteria in gastric cancer: an updated meta-analysis. Tumour Biol (2014) 1.56

Emergency department revisits for patients with kidney stones in California. Acad Emerg Med (2015) 1.56

Health care cost associated with prostate cancer, androgen deprivation therapy and bone complications. J Urol (2007) 1.56

Variation in treatment associated with life expectancy in a population-based cohort of men with early-stage prostate cancer. Cancer (2014) 1.55

Pregabalin for the treatment of men with chronic prostatitis/chronic pelvic pain syndrome: a randomized controlled trial. Arch Intern Med (2010) 1.55

Compliance with guidelines for patients with bladder cancer: variation in the delivery of care. Cancer (2011) 1.55

Trends in surgical mesh use for pelvic organ prolapse from 2000 to 2010. Obstet Gynecol (2012) 1.55

Prevalence and economic consequences of medication adherence in diabetes: a systematic literature review. Manag Care Interface (2006) 1.53

Clinical manifestation and management of primary malignant tumors of the cervical trachea. Eur Arch Otorhinolaryngol (2013) 1.53

Predicting quality of life after radical prostatectomy: results from CaPSURE. J Urol (2004) 1.52

A genome-wide association scan (GWAS) for mean telomere length within the COGS project: identified loci show little association with hormone-related cancer risk. Hum Mol Genet (2013) 1.52

Matching tumor risk with aggressiveness of treatment in men with multiple comorbidities and early-stage prostate cancer. Cancer (2013) 1.51

Health related quality of life in men with prostate cancer. J Urol (2003) 1.51

Assessment of four DNA fragments (COI, 16S rDNA, ITS2, 12S rDNA) for species identification of the Ixodida (Acari: Ixodida). Parasit Vectors (2014) 1.51

ERCC2/XPD Lys751Gln and Asp312Asn gene polymorphism and lung cancer risk: a meta-analysis involving 22 case-control studies. J Thorac Oncol (2010) 1.51

Economic impact and quality-of-life burden of allergic rhinitis. Curr Med Res Opin (2004) 1.50

Trends in the surgical management of stress urinary incontinence among female Medicare beneficiaries, 2002-2007. Urology (2013) 1.49

Quality of life in men undergoing active surveillance for localized prostate cancer. J Natl Cancer Inst Monogr (2012) 1.49

CUL4A induces epithelial-mesenchymal transition and promotes cancer metastasis by regulating ZEB1 expression. Cancer Res (2013) 1.48

Bone scan overuse in staging of prostate cancer: an analysis of a Veterans Affairs cohort. Urology (2011) 1.48

The effect of concomitant prolapse repair on sling outcomes. J Urol (2008) 1.47

The MAPP research network: a novel study of urologic chronic pelvic pain syndromes. BMC Urol (2014) 1.47

Hospice use and high-intensity care in men dying of prostate cancer. Arch Intern Med (2010) 1.45